SCHEMBL5588959

SCHEMBL5588959

CCOc1c(CC)c(CC)c(O)c(O)c1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 2/20 0.37
LDHB P07195 2/20 0.37
METAP2 P50579 1/20 0.34
MEN1 O00255 2/20 0.33
RAB9A P51151 2/20 0.33
KMT2A Q03164 2/20 0.33
THRB P10828 1/20 0.33
NPC1 O15118 1/20 0.33
APP P05067 1/20 0.32
BACE1 P56817 1/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 3/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAPT P10636 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
ABL1 P00519 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589152 0.86 LDHA (0.39) LDHALDHBMEN1KMT2ATSHR
SCHEMBL5588068 0.84 LDHA (0.38) LDHALDHBMETAP2MEN1KMT2A
SCHEMBL5587235 0.83 LDHA (0.49) LDHALDHBMEN1RAB9AKMT2A
SCHEMBL5587171 0.82 PLA2G2A (0.42) LDHALDHBMEN1KMT2ATHRB
SCHEMBL5590117 0.82 APP (0.35) LDHALDHBMETAP2MEN1RAB9A
SCHEMBL5586958 0.81 PLA2G2A (0.44) MEN1KMT2ATHRBTSHR
SCHEMBL5589712 0.81 PLA2G2A (0.44) MEN1KMT2ATHRBTSHR
SCHEMBL5589952 0.81 PLA2G2A (0.44) MEN1KMT2ATHRBTSHR
SCHEMBL5587043 0.81 PLA2G2A (0.44) MEN1KMT2ATHRBTSHR
SCHEMBL5590442 0.80 LDHA (0.43) LDHALDHBMEN1KMT2AAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LDHA 320/4885LDHB 486/4885METAP2 3428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.